Amneal Pharmaceuticals, Inc. — Director's Dealing 2019

May 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amneal Pharmaceuticals, Inc. (AMRX)
CIK: 0001723128
Period of Report: 2019-05-13

Reporting Person: BOYER ANDREW S (Exec VP, Comm Optns)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-13	Class A Common Stock	P	19000	$9.46	Acquired	29302	Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $9.00 per share to $9.75 per share. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.